Try BIOS and read our paper in the links below ↓
🔗 Try BIOS here: chat.bio.xyz
🔗 Tech blog: x.com/BioAIDevs/st...
🔗 arXiv paper, "Rethinking the AI Scientist": arxiv.org/abs/2601.12542
🔗 Join fellow builders and give feedback in our Bio AI Discord: discord.gg/vwMSHKh58X
Pro, Researcher and Lab subscription tiers offer discounted packages on monthly credits. Our usage-based pricing is competitive and in some cases significantly cheaper than leading scientific agents.
• Subagent Swarm: BIOS orchestrates subagents specializing in research functions (Literature Review, Data Analysis, Novelty Detection) and, soon, research domains (microbiology, longevity, genomics).
• Persistent World State: Rather than losing context as conversations grow, world state ensures investigations build on insights within each research cycle and across sessions.
• Human-in-the-Loop or Autonomous Mode: Intermediate checkpoints let researchers guide investigations mid-flight as insights emerge. No more waiting hours for batch runs + reruns to get results. Or, run in fully autonomous mode for extended investigations.
• Global SOTA on Data Analysis Benchmarks: BixBench 48.78% open-answer, 55.12% multiple-choice + refusal, 64.39% multiple-choice (no refusal) - outperforming systems like Edison Scientific and Kepler.
Meet BIOS, an AI Scientist built to orchestrate complex biomedical research.
Available now in Beta with free + paid tiers, exclusive launch pricing and, for limited time, free full access to academic users with a .edu email address. ↓
BIOS is available now in Beta with free + paid tiers, exclusive launch pricing and, for limited time, free full access to academic users with a .edu email address.
• Subagent Swarm: BIOS orchestrates subagents specializing in research functions (Literature Review, Data Analysis, Novelty Detection) and, soon, research domains (microbiology, longevity, genomics).
• Persistent World State: Rather than losing context as conversations grow, world state ensures investigations build on insights within each research cycle and across sessions.
• Human-in-the-Loop or Autonomous Mode: Intermediate checkpoints let researchers guide investigations mid-flight as insights emerge. No more waiting hours for batch runs + reruns to get results. Or, run in fully autonomous mode for extended investigations.
• Global SOTA on Data Analysis Benchmarks: BixBench 48.78% open-answer, 55.12% multiple-choice + refusal, 64.39% multiple-choice (no refusal) - outperforming systems like Edison Scientific and Kepler.
📚 Dive into the DeSci Playbook:
How crypto is reshaping scientific funding, coordination, and ownership.
Full episode with @jamessinka.bsky.social, Dr. Shelby , and Smac here → www.youtube.com/watch?v=rPTd...
Some scientific problems need deep technical focus and long horizons.
This is where tokens become powerful. They fund researchers and applied orgs working close to real inflection points and keep contributors aligned over time.
The long arc points toward disease-focused platforms.
> Focused capital.
> Continuous experimentation.
> Communities with a stake in every outcome.
Science becomes a network instead of a silo.
The end state of DeSci is a flywheel where capital, curiosity and data all move in the same direction.
Funding sparks experiments, experiments create insight, insight attracts more contributors, and the loop strengthens with every cycle. A different way to build scientific momentum.
Shelby and Smac wrote a playbook because researchers kept asking:
> How do tokens work
> How does funding move
> How does community coordination fit into biology
With the goal to build clarity for scientific builders.
A pattern is emerging.
- DeSci 1.0 DeSci came from crypto builders curious about biology.
- DeSci 2.0 comes from researchers who spent years in labs and want faster ways to bring ideas into the world.
People are tired of waiting for institutions to fix science. Builders are doing it themselves.
In this recent Biotech 2.0, James Sinka (Bio), Dr. Shelby and Smac from CompoundVC talked about the DeSci playbook, crypto tools for science and what Biotech 2.0 looks like 🧵
We'll dive into early learnings from the front-lines of Biotech 2.0 and the push to upgrade R&D for the network age.
RSVP here: luma.com/descitakeover
Join us this FRIDAY w/ Dr. Shelby & Smac from CompoundVC for a livestream exploring the current state of biotech and the role DeSci can play in bringing bold science to market faster & cheaper.
We’re in the early days of a step-function change in science.
One of the deepest bear markets in biotech’s 45-year history has sparked a quiet rebellion among scientists & engineers who want to build differently.
If you’re a PI, post-doc or independent researcher with a bold idea, you can apply to fund your research at bio.xyz/scientists.
Bio has already helped 60+ projects raise in fields like:
• Longevity
• Rare diseases
• Fertility
• Quantum biology
3️⃣ Funding then tracks your progress.
As you hit milestones and share results, additional funding unlocks, with projects accessing ~$1M over time.
2️⃣ Once live, supporters can fund your project.
Typical projects on Bio raise ~$50K–$100K at launch, giving teams enough runway to:
• Hire or extend staff
• Run key experiments
• Generate the next wave of data
Without the typical 6–12 month grant cycles.
1️⃣ Start with a hypothesis.
Bio works with you to turn it into a fundable project:
• Proposed experiments
• Milestones + budget
• Team + track record
Most researchers lack time, flexible funding, and a clear path to move fast.
With Bio, researchers can bootstrap bold science with direct support from a global community.
“We think it’s easier to build a new way to fund science than to fix the old one.” - 👨🏻🔬James Sinka, Chief Science Officer at Bio
Since 2023, projects have used Bio Protocol to raise $50M+ across hundreds of completed research deals.
The Bio Ecosystem is constantly evolving.
The next frontier of therapeutics, from brain health, longevity & gut health to rare diseases & more.
